CRWV exits its August 11 earnings print with the Street raising targets en masse, short sellers continuing to pare back, and options traders leaning bullish — a rare alignment of signals for a stock that spent much of the summer under active bear pressure.
The analyst response is the clearest story today. At least nine firms raised their price targets in the 24 hours following the print, with the upgrades skewing decisively upward. Wells Fargo lifted its target to $160 while maintaining Overweight. Cantor Fitzgerald moved to $176. Baird jumped to $130 from $100. Truist raised to $155. JP Morgan's Samik Chatterjee lifted his Neutral target to $120 from $110. The lone dissenting voice was Bernstein, which raised its Underperform target to $74 — but even that bear raised the number. The consensus picture is a Street that broadly sees upside, with bulls clustered in the $130–$176 range and the holdouts at Neutral not disputing the growth story, just the valuation. The mean price target sits near $140, implying roughly 55% potential from the current $90.32 close. One outlier — Rosenblatt at $250 — skews that mean meaningfully, though even excluding it, the bull targets are well above current levels.
Short positioning has continued the collapse described in prior notes. Shares short fell another 11% on the week to roughly 58.5 million, down more than 40% from the peak above 100 million seen in early July. That is a sustained, not sudden, exit from bearish conviction — bears who rebuilt aggressively into the August 11 print have since covered. SI % of free float is now around 15%, still elevated in absolute terms but the direction of travel is firmly lower. What makes the borrow picture less alarming than the SI level implies is availability: there are roughly two shares available to borrow for every one already lent out, an availability reading near 209% that reflects a relaxed lending market with no meaningful squeeze pressure. Cost to borrow has edged up 18% on the week but remains low in absolute terms at under 0.5% — this is not a stock where bears face punishing carry costs. The ORTEX short score has also eased, now at 62.2, down from 64.3 at the start of August, consistent with the unwinding trend.
Options positioning adds a mildly constructive tilt. The put/call ratio has slipped to 0.70, modestly below its 20-day average of 0.74, and the z-score of -0.73 indicates options traders are running slightly less defensive than usual. That is a meaningful shift from mid-July, when the PCR was running above 0.78. The move is not dramatic — this is not an aggressive bullish options setup — but it corroborates the short-covering narrative: the fear that dominated positioning into the print has partially unwound.
The ownership picture adds nuance. Founder and CEO Michael Intrator sold approximately $10.9 million in shares on August 4, a cluster of transactions across multiple price points. COO Sachin Jain sold $1.25 million on August 10. Both sales coincided with routine equity awards, a common pattern in post-IPO lockup structures, and significance scores on these trades are low. BlackRock added aggressively in the most recent reported period, picking up roughly 14.7 million shares to reach a 4.4% stake. Vanguard entities appear as fresh entrants. The institutional base is broadening even as founders and executives trim — a structural dynamic typical of names transitioning from venture-backed to broad institutional ownership.
The fundamental debate the Street is pricing around is unchanged: CoreWeave's revenue growth is exceptional, but concentration risk remains the central bear argument. The top three customers account for over 70% of revenue by the company's own disclosure, debt levels are high, and power access is a genuine operational constraint. The EPS momentum factor score of 90 over 30 days signals that near-term estimate revisions have been strongly positive — the print clearly beat expectations. But the 12-month forward EPS growth rank of just 20 out of 100 reflects that profitability remains distant; the stock carries a negative trailing PE and deeply negative free cash flow. Peers APLD and BBAI both moved in the same direction on the day, with APLD up 2.2% and BBAI up 3.1%, though APLD is down 5% on the week — suggesting the post-earnings lift for CRWV is at least partly idiosyncratic rather than pure sector rotation.
With the next earnings event not due until November 12, the near-term focus shifts to whether the analyst target-raise cycle translates into fresh institutional buying, and whether the short base — still at 15% of float despite the recent unwind — continues to compress or finds a floor.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
